Veracyte | VCYT - Marktkapitalisierung

Aktienkurs
31.09
Täglich Wechseln
-0.26 -0.83%
Monatlich
-4.22%
Jährlich
-2.23%
Q2 Prognose
30.24




Marktkapitalisierung Veränderung Datum
Agenus USD 107M 16M 2025-12
Agilent USD 37.86B 3.64B 2025-12
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 9.02B 4.25B 2025-12
Bruker USD 7.16B 2.23B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Illumina USD 20.62B 6.53B 2025-12
Karyopharm Therapeutics USD 652M 517M 2026-04
Laboratory Of America USD 20.8B 3.03B 2025-12
Myriad Genetics USD 575M 98M 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Siemens EUR 191.32B 7.96B 2025-12
Sonic Healthcare AUD 11.17B 1.7B 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Veracyte USD 3.33B 627M 2025-12
Waters USD 22.61B 5.25B 2025-12